shield-check-line
Third-Party Testing Results

Every batch is independently tested by Janoshik for quality and transparency.

Powered by TESTIDES
VERIFIED
This batch has passed all tests.

High purity and accurate concentration.

shield-check-line
Purity

High Purity

Identity
Confirmed
Concentration

Accurate

Compounds

No Harmful Additives

KLOW

1. Choose your dosage
Select the strength that's right for you.
2. Bundle & Save
Save more when you buy more.
Quantity
Total
$25 standard shipping across CanadaFree shipping on orders over $499
Quality & Transparency

Third-Party Testing Results

Every batch is independently tested by an accredited, third-party laboratory for purity, potency and safety.

Independent Lab Testing

Verified for purity and safety

Batch-Specific Reports

View COAs for every batch

Accredited Laboratories

Tested to industry standards

Full Transparency

Know what's in every lot

Product Information

KLOW is a commercial designation for an experimental combination of four peptides: GHK-Cu, BPC-157, TB-500, and KPV. The formulation is marketed for its proposed relationship to tissue repair, skin biology, inflammatory signaling, and regenerative processes.

Compound
GHK-CU
Dosage
50mg
Compound
KPV
Dosage
10mg
Compound
BPC-157
Dosage
10mg
Compound
TB-500
Dosage
10mg
Product Form
Lyophilized Powder Single Vial
Storage
Refrigerate After Reconstitution

Mechanism of Action

KLOW is a commercial designation for an experimental combination of four peptides: GHK-Cu, BPC-157, TB-500, and KPV. The formulation is marketed for its proposed relationship to tissue repair, skin biology, inflammatory signaling, and regenerative processes.

Cellular Migration and Tissue Repair

Research involving BPC-157 and thymosin beta-4-related compounds has explored cellular signaling pathways associated with tissue maintenance and repair. These findings provide a rationale for further investigation, but the activity of TB-500 must be distinguished from that of full-length thymosin beta-4.

Vascular Signaling

Preclinical research has investigated BPC-157 and thymosin beta-4-related biology in relation to angiogenesis and vascular signaling. Whether these proposed effects translate into meaningful clinical outcomes when the compounds are combined remains unknown.

Inflammatory and Cellular Stress Responses

Experimental studies have explored the potential effects of individual components on inflammatory signaling, oxidative stress, and tissue remodeling. The contribution of each ingredient to the combined formulation has not been established, and no validated synergistic effect has been demonstrated.

3. Areas of Scientific Investigation

Skin appearance: Research into GHK-Cu and its potential relationship to skin structure and remodeling.

Extracellular matrix biology: Investigation of collagen-related pathways and connective-tissue organization.

Tissue repair: Preclinical research into cellular processes associated with injury and recovery.

Vascular biology: Exploration of angiogenesis and tissue perfusion pathways.

Inflammatory signaling: Investigation of cellular responses associated with tissue damage and repair.

Regenerative biology: Exploratory research into the mechanisms that support tissue maintenance.

These areas describe research interests and proposed applications, not established clinical indications for GLOW.

Pharmacokinetic and Safety Considerations

The pharmacological characteristics of the combined formulation have not been adequately established.

Pharmacokinetics: Human absorption, distribution, metabolism, clearance, and half-life have not been sufficiently characterized for GLOW as a combination.

Dose-Response Relationship: No validated therapeutic dosing regimen or treatment duration has been established for the combined product.

Combined Effects: Potential interactions between GHK-Cu, BPC-157, and TB-500 remain insufficiently studied. The safety profile of each ingredient cannot be assumed to predict the safety of the combination.

Immunogenicity: Peptide aggregation, impurities, and formulation characteristics may contribute to immune reactions, particularly with injectable preparations.

Shipping

We ship discreetly across Canada using tracked shipping.

  • $25 standard shipping across Canada
  • Free shipping on orders over $499
  • Orders processed within 1–2 business days
  • Tracking number provided via email

FAQ

Before reconstitution, this product is stable at room temperature for short periods, such as during shipping, but refrigeration is recommended for longer-term storage. After reconstitution, it must be refrigerated. Keep away from direct light. This product is stored refrigerated until it ships.

Peptides are made up of chains of amino acids, and some of those amino acids are hydrophobic — meaning they don’t interact well with water. When a peptide contains a high percentage of these hydrophobic residues, it tends to resist dissolving in water and will aggregate, or clump together. These clumps can then trap water, forming a gel-like or stringy texture rather than dissolving into a nice, smooth solution.

Other contributing factors include:

High peptide concentration – Crowding the solution can push molecules together.

pH and temperature – Solubility can vary depending on how acidic or warm the environment is.

Solvent selection – Some peptides do better with alternatives to bacteriostatic water, such as acetic acid or DMSO.

Reconstitution speed – Adding diluent too quickly can shock the peptide into clumping.

Even if the peptide isn’t highly hydrophobic, under the right (or wrong) circumstances, it can still temporarily behave this way.

While nearly any peptide can gel under the right conditions, some are well-known for their gelling tendencies. Here’s a list of the usual suspects:

AOD-9604
Probably the most infamous of all — AOD tends to form a thick, stringy gel if not handled carefully. This one is very hydrophobic and sensitive to temperature and concentration.

GHK-Cu
Copper-bound peptides like GHK-Cu can form gels or crystals depending on the solvent used and the ambient pH. Copper itself doesn’t help the solubility much.

Thymosin Beta-4 (TB-500)
While this one often dissolves well at lower concentrations, it can develop a gel-like consistency if overdosed into a small volume of liquid.

Melanotan II

Known for being finicky, MT2 can clump or gel, especially if it’s cold when reconstituted or the water is added too quickly.

CJC-1295 (DAC and non-DAC)

This longer peptide sometimes forms viscous solutions, especially when not given time to dissolve fully. It benefits from warm temps and slow mixing.

BPC-157

BPC usually dissolves well, but under some conditions (like high concentration or cold storage), it may start to gel or form strands.

IGF-1 LR3

This is more rare, but at high concentrations or if pH is off, this growth factor can aggregate and become cloudy or sticky.

Epitalon

A short peptide, but still known to occasionally form light gels — especially if the reconstitution environment is less than ideal.

Selank / Semax Variants

These nootropic peptides are usually stable but have been reported to gel when compounded at higher concentrations or exposed to rapid temperature changes.

If you’re dealing with a gelling peptide, here are a few simple tips that can help bring it back into proper solution:

1. Warm the vial gently

Let the vial come to room temperature before reconstituting. If needed, place it in a warm (not hot!) water bath for a few minutes to loosen things up.

2. Add your solvent slowly

Instead of blasting bacteriostatic water into the vial, let it drip slowly down the side. This allows the peptide to dissolve gradually and reduces shock to the material.

3. Swirl, don’t shake

Shaking creates bubbles and doesn’t help dissolve aggregates. A gentle swirl or rolling the vial between your hands is more effective.

4. Let it sit

Sometimes the peptide just needs time. Let it rest after adding solvent, then check back in 10–15 minutes and gently swirl again.

5. Try an alternate solvent

If the peptide still doesn’t dissolve, small amounts of 0.6% acetic acid or even DMSO (for research use only) can help break up stubborn hydrophobic clumps.

6. Dilute further if needed

If you’re working with a very high concentration, it may be helpful to use a larger volume of solvent to encourage full dissolution.

Peptide gelling is not a quality issue, nor is it a manufacturing problem — it’s simply a result of biochemical properties interacting with water and environment. Hydrophobic sequences, high concentrations, or quick handling can all lead to temporary clumping or gel formation.

With a little patience and the right technique, almost all gelling issues can be reversed or avoided. If you work with these peptides regularly, getting familiar with their personalities — and knowing how to coax them into solution — will save you time and frustration.
So next time your peptide gels, just remember: it’s not broken — it’s just being dramatic.